Millendo closes enrolment for first part of livoletide’s ZEPHYR trial

PWS is a rare genetic disease that causes hyperphagia, which is chronic unrelenting hunger. Credit: Gerd Altmann from Pixabay.



  • livoletide ZEPHYR trial enrolment